NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ImYoo

ImYoo

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.imyoo.health/

Last Round

Accelerator

Dec 2, 2024

Total Funding Raised

$100,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

ImYoo is a biotechnology company that provides a patient-enabled biodiscovery platform for at-home blood sample collection and single-cell multi-omic analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Usage-Based SaaS, Revenue Share

AI Layer

Application

Keywords

biodiscovery platformat-home blood collectionmulti-omicssingle-cell analysislongitudinal datascRNA-seqbiomarker discoverypatient stratificationdecentralized clinical trialsAI drug discoveryclinical trial supportprecision medicineautoimmune diseasebiological digital twinimmune atlaspatient-centric research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ImYoo Comparables

Compare ImYoo with similar companies based on industry and business-model similarity.

ImYoo comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

ImYoo Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 2, 2024
SeedJul 31, 2022

Key People

Founding team and executive leadership

Tatyana Dobreva

Chief Executive Officer

Executive Team

ImYoo Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors grew 548% MoM, reaching 1.1K.

  • Jul 19, 2025

    Grew 43% QoQ from 7 to 10 employees.

ImYoo Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

ImYoo Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ImYoo's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range12
Year FoundedN/A
Last FundingDec 2, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.